Our core focus is high-quality clinical trials designed for sponsors seeking FDA, TGA or EMA registration of novel drugs. - FDA 505(b)2 and EMA Regulatory expertise for cannabinoids and entheogens - In-house clinical experts on cannabinoids - Partnerships with cGMP CDMOs with clinical trial capabilities - Multiple inpatient and outpatient sites with a dedicated interest in using novel cannabinoids and entheogens Do you have a research project you would like to enquire about, or would like to learn more about Clinical Research in Australia ? Contact: hello@ingenucro.com.au